116
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Dimers of the Neuropeptide Y (NPY) Y2 Receptor Show Asymmetry in Agonist Affinity and Association with G Proteins

, , , , , & show all
Pages 437-451 | Published online: 19 Nov 2008

REFERENCES

  • K D Ridge, and K Palczewski. 2007. Visual rhodopsin sees the light: Structure and mechanism of G protein signaling. J Biol Chem 282:9297–9301.
  • G Milligan, and N J Smith. 2007. Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends Pharmacol Sci 28:615–620.
  • G Milligan. 2007. A day in the life of a G protein-coupled receptor: The contribution to function of G protein-coupled receptor dimerization. Br J Pharmacol 147:S46–S57.
  • J L Baneres, and J Parello. 2003. Structure-based analysis of GPCR function: Evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 329:815–829.
  • K Herrick-Davis, E Grinde, T J Harrigan, and J E Mazurkiewicz. 2005. Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: Receptor dimers bind two molecules of ligand and one G-protein. J Biol Chem 280:40144–40151.
  • F Novi, L Stanasila, F Giorgi, G U Corsini, S Cotecchia, and R Maggio. 2005. Paired activation of two components within muscarinic M3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane. J Biol Chem 280:19768–19776.
  • P S Park, S Filipek, J W Wells, and K Palczewski. 2004. Oligomerization of G protein-coupled receptors: Past, present, and future. Biochemistry 43:15643–15656.
  • M C Dinger, J E Bader, A D Kobor, A K Kretzschmar, and A G Beck-Sickinger. 2003. Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J Biol Chem 278:10562–10571.
  • M M Berglund, D A Schober, M A Esterman, D R Gehlert, and Y Neuropeptide. 2003. Y4 receptor homodimers dissociate upon agonist stimulation. J Pharmacol Exp Ther 307:1120–1126.
  • M S Parker, M M Berglund, I Lundell, and S L Parker. 2001. Blockade of pancreatic polypeptide-sensitive neuropeptide Y (NPY) receptors by agonist peptides is prevented by modulators of sodium transport. Implications for receptor signaling and regulation. Peptides 22:887–898.
  • R Sah, A Balasubramaniam, M S Parker, F Sallee, and S L Parker. 2005. Neuropeptide Y as a partial agonist of the Y1 receptor. Eur J Pharmacol 525:60–68.
  • F M Dautzenberg, and S Neysari. 2005. Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors. Pharmacology 75:21–29.
  • R Hilal-Dandan, S Villegas, A Gonzalez, and L L Brunton. 1997. The quasi-irreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes. J Pharmacol Exp Ther 281:267–273.
  • E Grantcharova, J Furkert, H P Reusch, H W Krell, G Papsdorf, M Beyermann, R Schulein, W Rosenthal, and A Oksche. 2002. The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process. J Biol Chem 277:43933–43941.
  • P J Brighton, P G Szekeres, A Wise, and G B Willars. 2004. Signaling and ligand binding by recombinant neuromedin U receptors: Evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction. Mol Pharmacol 66:1544–1556.
  • Y Liang, D Fotiadis, S Filipek, D A Saperstein, K Palczewski, and A Engel. 2003. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 278:21655–21662.
  • M Nobles, A Benians, and A Tinker. 2005. Heterotrimeric G proteins precouple with G protein-coupled receptors in living cells. Proc Natl Acad Sci USA 102:18706–18711.
  • S L Parker, M S Parker, F R Sallee, and A Balasubramaniam. 2007. Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins. Regul Pept 144:72–81.
  • A Salahpour, S Angers, J F Mercier, M Lagace, S Marullo, and M Bouvier. 2004. Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 279:33390–33397.
  • D J Dupre, M Robitaille, N Ethier, L R Villeneuve, A M Mamarbachi, and T E Hebert. 2006. Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking. J Biol Chem 281:34561–34573.
  • S Pidasheva, M Grant, L Canaff, O Ercan, U Kumar, and G N Hendy. 2006. Calcium-sensing receptor dimerizes in the endoplasmic reticulum: Biochemical and biophysical characterization of CASR mutants retained intracellularly. Hum Mol Genet 15:2200–2209.
  • S L Parker, M S Parker, R Sah, A Balasubramaniam, and F R Sallee. 2008. Pertussis toxin induces parallel loss of neuropeptide Y Y(1) receptor dimers and G(i) alpha subunit function in CHO cells. Eur J Pharmacol 579:13–25.
  • P J Munson, and D Rodbard. 1980. LIGAND: A versatile computerized approach for characterization of ligand-binding proteins. Anal Biochem 107:220–239.
  • S L Parker, M S Parker, M A Estes, Y Y Wong, R Sah, T Sweatman, E A Park, A Balasubramaniam, and F R Sallee. 2008. The neuropeptide Y (NPY) Y2 receptors are largely dimeric in the kidney, but monomeric in the forebrain. Journal of Receptors and Signal Transduction 28:245–263.
  • B Jastrzebska, T Maeda, L Zhu, D Fotiadis, S Filipek, A Engel, R E Stenkamp, and K Palczewski. 2004. Functional characterization of rhodopsin monomers and dimers in detergents. J Biol Chem 279:54663–54675.
  • J P Grierson, and J Meldolesi. 1995. Calcium homeostasis in mouse fibroblast cells: Affected by U-73122, a putative phospholipase C beta blocker, via multiple mechanisms. Br J Pharmacol 115:11–14.
  • S L Parker, M S Parker, T Sweatman, and W R Crowley. 1998. Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C. J Pharmacol Exp Ther 286:382–391.
  • S Misra, K S Murthy, H Zhou, and J R Grider. 2004. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways. J Pharmacol Exp Ther 311:1154–1162.
  • O Ben-Zeev, H Z Mao, and M H Doolittle. 2002. Maturation of lipoprotein lipase in the endoplasmic reticulum. Concurrent formation of functional dimers and inactive aggregates. J Biol Chem 277:10727–10738.
  • H H Cheng, L Xu, H Kumagai, and R D Simoni. 1999. Oligomerization state influences the degradation rate of 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem 274:17171–17178.
  • S K Kim, and K A Jacobson. 2006. Computational prediction of homodimerization of the A3 adenosine receptor. J Mol Graph Model 25:549–561.
  • S P Alexander, A Mathie, and J A Peters. 2007. 7TM Receptors. Br J Pharmacol 150 (Suppl 1):S4–S81.
  • M Filizola, S X Wang, and H Weinstein. 2006. Dynamic models of G-protein coupled receptor dimers: Indications of asymmetry in the rhodopsin dimer from molecular dynamics simulations in a POPC bilayer. J Comput Aided Mol Des 20:405–416.
  • P Kota, P J Reeves, U L Rajbhandary, and H G Khorana. 2006. Opsin is present as dimers in COS1 cells: Identification of amino acids at the dimeric interface. Proc Natl Acad Sci USA 103:3054–3059.
  • J J Leban, D Heyer, A Landavazo, J Matthews, A Aulabaugh, and A J Daniels. 1995. Novel modified carboxy terminal fragments of neuropeptide Y with high affinity for Y2-type receptors and potent functional antagonism at a Y1-type receptor. J Med Chem 38:1150–1157.
  • L Gazi, S A Nickolls, and P G Strange. 2003. Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: Evidence for agonist regulation of G protein selectivity. Br J Pharmacol 138:775–786.
  • P Walker, M Munoz, R Martinez, and M C Peitsch. 1994. Acidic residues in extracellular loops of the human Y1 neuropeptide Y receptor are essential for ligand binding. J Biol Chem 269:2863–2869.
  • W Guo, L Shi, M Filizola, H Weinstein, and J A Javitch. 2005. Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci USA 102:17495–17500.
  • M Berthouze, L Rivail, A Lucas, M A Ayoub, O Russo, S Sicsic, R Fischmeister, I Berque-Bestel, R Jockers, and F Lezoualc'h. 2007. Two transmembrane Cys residues are involved in 5-HT4 receptor dimerization. Biochem Biophys Res Commun 356:642–647.
  • J G Baker, and S J Hill. 2007. Multiple GPCR conformations and signalling pathways: Implications for antagonist affinity estimates. Trends Pharmacol Sci 28:374–381.
  • S R Hoare, S K Sullivan, D A Schwarz, N Ling, W W Vale, P D Crowe, and D E Grigoriadis. 2004. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists. Biochemistry 43:3996–4011.
  • I D Alves, K A Ciano, V Boguslavski, E Varga, Z Salamon, H I Yamamura, V J Hruby, and G Tollin. 2004. Selectivity, cooperativity, and reciprocity in the interactions between the delta-opioid receptor, its ligands, and G-proteins. J Biol Chem 279:44673–44682.
  • A B Tobin. 2008. G-protein-coupled receptor phosphorylation: Where, when and by whom. Br J Pharmacol 153 (Suppl 1):S167–176.
  • M R Whorton, B Jastrzebska, P S Park, D Fotiadis, A Engel, K Palczewski, and R K Sunahara. 2008. Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer. J Biol Chem 283:4387–4394.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.